A missense polymorphism in the PTPN13 gene (rs989902) associated with the risk of colorectal and gastric cancers in an Iranian population
Open Access
- 14 June 2026
- journal article
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 27 (1)
Abstract
Background/aim: Given that phosphorylation/dephosphorylation of many important proteins at tyrosine residues play a vital role in various cellular functions, it can be inferred that protein tyrosine phosphatase enzymes, including the protein tyrosine phosphatase non-receptor type 13 ( PTPN13 ), are involved in numerous critical cellular processes. PTPN13 influences several signaling pathways and biological activities, suggesting a potential role in carcinogenesis. This study aimed to select the most relevant PTPN13 polymorphism using “polymorphism selection index” (PSI) and investigate its association with gastric (GC) and colorectal (CRC) cancer risk. Methods: Missense polymorphisms with minor allele frequency ≥ 0.01 were retrieved and PSI was calculated for each. We conducted two case-control studies in an Iranian population (197 CRC/215 controls; 150 GC/230 controls). Genotyping was carried out by PCR-RFLP. Associations with cancer risk were assessed using odds ratios (ORs) and 95% confidence intervals (CIs). Results: Among seven missense polymorphisms, rs989902 (T > G, Y2081D) had the highest PSI and was selected. Consequently, we focused on investigating the association between this polymorphism and the risk of CRC and GC. The GG genotype was found to increase the risk of both cancers (for CRC: OR = 2.36, 95% CI = 1.18–4.69, p = 0.014; for GC: OR = 2.14, 95% CI = 1.06–4.31, p = 0.033). Conclusion: This study demonstrates that the rs989902 is significantly associated with the risk of CRC and GC in an additive manner. Furthermore, the cancer risk elevated with an increasing number of combined risk factors, including the rs989902-GG genotype, smoking, and family history of cancer, highlighting the importance of this genetic variant in the etiology of these malignancies.Keywords
This publication has 29 references indexed in Scilit:
- Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancerCell Research, 2026
- Mechanisms, functions and therapeutic targeting of protein tyrosine phosphatasesNature Reviews Molecular Cell Biology, 2025
- PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancerAnnals of Medicine, 2023
- A general framework for estimating the relative pathogenicity of human genetic variantsNature Genetics, 2014
- Deletion of chromosome 4q predicts outcome in Stage II colon cancer patientsCellular Oncology, 2011
- Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancersJournal of Cancer Research and Clinical Oncology, 2009
- Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomasPathology, 2008
- Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signalingOncogene, 2007
- FAS Associated Phosphatase (FAP-1) Blocks Apoptosis of Astrocytomas through Dephosphorylation of FASJournal of Neuro-Oncology, 2005
- Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins.Journal of Biological Chemistry, 1994